Congressionally Directed Medical Research Programs

The Congressionally Directed Medical Research Programs (CDMRP) is a U.S. Department of Defense biomedical research programme that allocates congressional appropriations to fund high-impact, high-risk studies addressing military and veteran health priorities. It has funded clinical trials of psychedelic-assisted treatments for PTSD and traumatic brain injury in Service Members through its Defense Medical Research and Development Program, with over $1.27 billion appropriated for FY2026.